Skip to main content
. 2021 Mar 23;21:315–324. doi: 10.1016/j.omtm.2021.03.011

Figure 2.

Figure 2

Manufacturing of autologous PBMC-derived antigen-presenting feeder cells

(A) Expression of truncated HER2, CD80, and 4-1BBL on the cell surface of antigen-presenting feeder cells 24 h post-electroporation. (B) Percentage of truncated HER2, CD80, and 4-1BBL-positive cells over time for 5 days after transduction.